Mifepristone Market Overview
The Mifepristone Market was valued at $700 million in 2024 and is projected to reach $1.2 billion by 2035, growing at a CAGR of 4.4%. Mifepristone is a progesterone receptor antagonist primarily used for medical abortion, induction of labor, and management of miscarriage. Its increasing acceptance as a safe alternative to surgical procedures drives sustained market demand. The market is...
0 Comments 0 Shares 115 Views 0 Reviews